Dr Martin L Miller MSc PhD
Martin is a Junior Group Leader at the Cancer Research UK Cambridge Institute. His research is focused on cell-cell interactions in the tumour microenvironment and unravelling stroma-mediated drug resistance in human cancers using proteomic technologies.
Professor Ashok Venkitaraman
Ashok Venkitaraman holds the Ursula Zoellner Professorship of Cancer Research at the University of Cambridge, and is the Director of the Medical Research Council (MRC) Cancer Cell Unit. He leads a multidisciplinary initiative that aims to pioneer new approaches for chemical biology and the development of small-molecule therapeutics.
Dr David Adams
David is a Senior Group Leader at the Wellcome Trust Sanger Institute, a CRUK Senior Fellow, and Adjunct Faculty at the Cambridge Cancer Research Institute. His research has focused on the development of models of human disease.
Professor Douglas Fearon
Doug is the Emeritus Sheila Joan Smith Professor of Immunology, University of Cambridge, and Senior Group Leader at the Cancer Research UK Cambridge Institute. His career has focused on studies of basic immune mechanisms involved in tissue damage and host defense.
Professor John Griffiths
John is Professor of Magnetic Resonance Applied to Cancer in Cambridge University and Senior Group Leader and co-Director of Imaging at the Cancer Research UK Cambridge Institute. He introduced the use of Magnetic Resonance Spectroscopy to monitor cancers in vivo, and since then his group has continued to work on the use of both that method and MR imaging for monitoring and treating cancer.
Professor Kevin Brindle
Kevin is Professor of Biomedical Magnetic Resonance in the Department of Biochemistry at the University of Cambridge and a senior group leader in the Cancer Research UK Cambridge Institute. Since 2006 he has been working on metabolic imaging with hyperpolarized 13C-labelled cell substrates to detect treatment response in tumours.